TIDMMDC
RNS Number : 3423H
Mediclinic International plc
06 June 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
6 June 2017
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Vesting of awards under the Company's Forfeitable Share Plan
The awards of ordinary shares in Mediclinic (the "Shares") set
out in the table below, granted on 31 July 2014, vested under the
Company's Forfeitable Share Plan on 31 May 2017.
Name Director/ Number Number Number
PDMR of Shares of Shares of Shares
vested sold at retained(1)
ZAR 130.44
per share
--------------------- ----------- ----------- ------------ -------------
Danie Meintjes Director 49,423 0 49,423
--------------------- ----------- ----------- ------------ -------------
Gert Hattingh PDMR 14,734 0 14,734
--------------------- ----------- ----------- ------------ -------------
Koert Pretorius PDMR 19,806 19,806 0
--------------------- ----------- ----------- ------------ -------------
David Hadley PDMR 9,778 9,778 0
--------------------- ----------- ----------- ------------ -------------
Dr Ole Wiesinger(1) PDMR 17,506 0 17,506
--------------------- ----------- ----------- ------------ -------------
Dr Ronnie
van der Merwe PDMR 16,507 16,507 0
--------------------- ----------- ----------- ------------ -------------
1. Dr Wiesinger was granted a conditional right to 17,506 Shares
under the Country Schedule to the Forfeitable Share Plan on 31 July
2014. On 1 June 2017, Dr Wiesinger elected to receive the award in
Shares, which he received on 5 June 2017.
The following notification made in accordance with Articles 19.1
and 19.3 of the Market Abuse Regulation relates to the Company's
Forfeitable Share Plan.
1. Details of PDMR / person closely associated
with them ("PCA")
--- -------------------------------------------------------------
a) Name Daniƫl Petrus Meintjes
--- --------------------- --------------------------------------
2. Reason for the notification
--- -------------------------------------------------------------
a) Position Chief Executive Officer of the
/ status Company
--- --------------------- --------------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- --------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- --------------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- --------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
--- --------------------- --------------------------------------
b) Nature of Vesting of award over 49,423 ordinary
the transaction shares awarded under the Company's
Forfeitable Share Plan
--- --------------------- --------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ---------- ----------
Nil cost 49,423
---------- ----------
--- --------------------- --------------------------------------
d) Aggregated
information
Aggregated
volume 49,423
Price
Nil cost
--- --------------------- --------------------------------------
e) Date of the 1 June 2017
transaction
--- --------------------- --------------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- --------------------------------------
1. Details of PDMR / person closely associated
with them ("PCA")
--- -------------------------------------------------------------
a) Name Gert C Hattingh
--- --------------------- --------------------------------------
2. Reason for the notification
--- -------------------------------------------------------------
a) Position Chief Corporate Services Officer
/ status of the Company
--- --------------------- --------------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- --------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- --------------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- --------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
--- --------------------- --------------------------------------
b) Nature of Vesting of award over 14,734 ordinary
the transaction shares awarded under the Company's
Forfeitable Share Plan
--- --------------------- --------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ---------- ----------
Nil cost 14,734
---------- ----------
--- --------------------- --------------------------------------
d) Aggregated
information
Aggregated
volume 14,734
Price
Nil cost
--- --------------------- --------------------------------------
e) Date of the 1 June 2017
transaction
--- --------------------- --------------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- --------------------------------------
1. Details of PDMR / person closely associated
with them ("PCA")
--- ------------------------------------------------------------
a) Name Koert Hendrik S Pretorius
--- --------------------- -------------------------------------
2. Reason for the notification
--- ------------------------------------------------------------
a) Position Chief Executive Officer - Mediclinic
/ status Southern Africa
--- --------------------- -------------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- -------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ------------------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- -------------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- -------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
--- --------------------- -------------------------------------
b) Nature of 1. Vesting of award over 19,806
the transaction ordinary shares awarded under
the Company's Forfeitable Share
Plan
2. Sale of 19,806 ordinary shares.
--- --------------------- -------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) --------------- ----------
1. Nil cost 1. 19,806
--------------- ----------
2. ZAR 130.44 2. 19,806
--------------- ----------
--- --------------------- -------------------------------------
d) Aggregated 1. 19,806
information
Aggregated 2. 19,806
volume
Price 1. Nil cost
2. ZAR 130.44
--- --------------------- -------------------------------------
e) Date of the 1 June 2017
transaction
--- --------------------- -------------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- -------------------------------------
1. Details of PDMR / person closely associated
with them ("PCA")
--- ------------------------------------------------------------
a) Name David J Hadley
--- --------------------- -------------------------------------
2. Reason for the notification
--- ------------------------------------------------------------
a) Position Chief Executive Officer - Mediclinic
/ status Middle East
--- --------------------- -------------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- -------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ------------------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- -------------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- -------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
--- --------------------- -------------------------------------
b) Nature of 1. Vesting of award over 9,778
the transaction ordinary shares awarded under
the Company's Forfeitable Share
Plan
2. Sale of 9,778 ordinary shares.
--- --------------------- -------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) --------------- ----------
1. Nil cost 1. 9,778
--------------- ----------
2. ZAR 130.44 2. 9,778
--------------- ----------
--- --------------------- -------------------------------------
d) Aggregated 1. 9,778
information
Aggregated 2. 9,778
volume
Price 1. Nil cost
2. ZAR 130.44
--- --------------------- -------------------------------------
e) Date of the 1 June 2017
transaction
--- --------------------- -------------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- -------------------------------------
1. Details of PDMR / person closely associated
with them ("PCA")
--- ------------------------------------------------------------
a) Name Dr Thorsten Ole Wiesinger
--- --------------------- -------------------------------------
2. Reason for the notification
--- ------------------------------------------------------------
a) Position Chief Executive Officer - Hirslanden
/ status
--- --------------------- -------------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- -------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ------------------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- -------------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- -------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
--- --------------------- -------------------------------------
b) Nature of Vesting of conditional right to
the transaction 17,506 Shares under the Country
Schedule to the Forfeitable Share
Plan on 31 July 2014
--- --------------------- -------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) ---------- ----------
Nil cost 17,506
---------- ----------
--- --------------------- -------------------------------------
d) Aggregated 17,506
information Nil cost
Aggregated
volume
Price
--- --------------------- -------------------------------------
e) Date of the 5 June 2017
transaction
--- --------------------- -------------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- -------------------------------------
1. Details of PDMR / person closely associated
with them ("PCA")
--- -----------------------------------------------------------
a) Name Dr Carel A van der Merwe
--- --------------------- ------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position Chief Clinical Officer of the
/ status Company
--- --------------------- ------------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- ------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- ------------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- ------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
--- --------------------- ------------------------------------
b) Nature of 1. Vesting of award over 16,507
the transaction ordinary shares awarded under
the Company's Forfeitable Share
Plan
2. Sale of 16,507 ordinary shares.
--- --------------------- ------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) --------------- ----------
1. Nil cost 1. 16,507
--------------- ----------
2. ZAR 130.44 2. 16,507
--------------- ----------
--- --------------------- ------------------------------------
d) Aggregated 1. 16,507
information
Aggregated 2. 16,507
volume
Price 1. Nil cost
2. ZAR 130.44
--- --------------------- ------------------------------------
e) Date of the 1 June 2017
transaction
--- --------------------- ------------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- ------------------------------------
About Mediclinic International plc
Mediclinic is an international private healthcare group with
operating platforms in Southern Africa (South Africa and Namibia),
Switzerland and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing acute care,
specialist-orientated, multi-disciplinary healthcare services.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic
Southern Africa operates 49 hospitals and 2 day clinics throughout
South Africa and 3 hospitals in Namibia with more than 8 000
inpatient beds in total; Hirslanden operates 16 private acute care
facilities and 4 clinics in Switzerland with more than 1 600
inpatient beds; and Mediclinic Middle East operates 6 hospitals and
31 clinics with more than 700 inpatient beds in the United Arab
Emirates.
During February 2016, the combination of the Company (previously
named Al Noor Hospitals Group plc), with operations mainly in Abu
Dhabi in the United Arab Emirates, and Mediclinic International
Limited was completed. Mediclinic International Limited was a South
African based international private healthcare group founded in
1983 and listed on the JSE, the South African stock exchange, since
1986, with operations in South Africa, Namibia, Switzerland and the
United Arab Emirates (mainly in Dubai). The combination resulted in
the renaming of the enlarged group to Mediclinic International
plc.
Mediclinic has a primary listing on the Main Market of the LSE,
with secondary listings on the JSE in South Africa and the NSX in
Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH,
United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBLGDLXXGBGRL
(END) Dow Jones Newswires
June 06, 2017 12:42 ET (16:42 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2023 to Apr 2024